Cargando…

Magnetic Resonance Imaging–targeted Prostate Biopsy Compared with Systematic Prostate Biopsy in Biopsy-naïve Patients with Suspected Prostate Cancer

BACKGROUND: It remains uncertain whether transrectal ultrasound (TRUS)-guided systematic biopsies can be omitted and rely solely on multiparametric magnetic resonance imaging–targeted biopsies (MRI-TBx) in biopsy-naïve men suspected of prostate cancer (PCa). OBJECTIVE: To compare PCa detection in bi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alkema, Nicolette G., Hoogeveen, Sebastiaan F.J.S., Cauberg, Evelyne C.C., Witte, Lambertus P.W., van 't Veer-ten Kate, Miranda, de Boer, Erwin, Hoogland, Marije A.M., Blanker, Marco H., Boomsma, Martijn F., Steffens, Martijn G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Prostate Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520499/ https://www.ncbi.nlm.nih.gov/pubmed/36185584 http://dx.doi.org/10.1016/j.euros.2022.08.005

Ejemplares similares

Reducing Biopsies and Magnetic Resonance Imaging Scans During the Diagnostic Pathway of Prostate Cancer: Applying the Rotterdam Prostate Cancer Risk Calculator to the PRECISION Trial Data
por: Remmers, Sebastiaan, et al.
Publicado: (2021)

Multiparametric Magnetic Resonance Imaging of the Prostate and Prostate-specific Membrane Positron Emission Tomography Prior to Prostate Biopsy (MP4 Study)
por: Woo, Henry H., et al.
Publicado: (2022)

Prostate Cancer Risk Inflation as a Consequence of Image-targeted Biopsy of the Prostate: A Computer Simulation Study
por: Robertson, Nicola L., et al.
Publicado: (2014)

External Validation of the Prostate Biopsy Collaborative Group Risk Calculator and the Rotterdam Prostate Cancer Risk Calculator in a Swedish Population-based Screening Cohort
por: Chandra Engel, Jan, et al.
Publicado: (2022)

Clinical Value of a Routine Urine Culture Prior to Transrectal Prostate Biopsy
por: Örtegren, Joakim, et al.
Publicado: (2022)

Which Prostate Cancers are Undetected by Multiparametric Magnetic Resonance Imaging in Men with Previous Prostate Biopsy? An Analysis from the PICTURE Study
por: Norris, Joseph M., et al.
Publicado: (2021)

Association Between a 22-feature Genomic Classifier and Biopsy Gleason Upgrade During Active Surveillance for Prostate Cancer
por: Press, Benjamin H., et al.
Publicado: (2022)

Improving the safety and tolerability of local anaesthetic outpatient transperineal prostate biopsies: A pilot study of the CAMbridge PROstate Biopsy (CAMPROBE) method
por: Thurtle, D, et al.
Publicado: (2018)

Hundred years of transperineal prostate biopsy
por: Schmeusser, Benjamin, et al.
Publicado: (2022)

Reassessment of Prostate Biopsy Specimens for Patients Referred for Robot-assisted Radical Prostatectomy Rarely Influences Surgical Planning
por: Hoekstra, Robert J., et al.
Publicado: (2021)

Prostate Cancer Detection Rate of Manually Operated and Robot-assisted In-bore Magnetic Resonance Imaging Targeted Biopsy
por: Sandahl, Mads, et al.
Publicado: (2022)

An Magnetic Resonance Imaging–directed Targeted-plus-perilesional Biopsy Approach for Prostate Cancer Diagnosis: “Less Is More”
por: Hagens, Marinus J., et al.
Publicado: (2022)

A Novel Risk Calculator Incorporating Clinical Parameters, Multiparametric Magnetic Resonance Imaging, and Prostate-Specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Risk Stratification Before Transperineal Prostate Biopsy
por: Kelly, Brian D., et al.
Publicado: (2023)

Role of Prophylactic Antibiotics in Transperineal Prostate Biopsy: A Systematic Review and Meta-analysis
por: Basourakos, Spyridon P., et al.
Publicado: (2022)

Quantifying the Effect of Location Matching on Accuracy of Multiparametric Magnetic Resonance Imaging Prior to Prostate Biopsy—A Multicentre Study
por: Gavin, Dominic James, et al.
Publicado: (2020)

An optimized prostate biopsy strategy in patients with a unilateral lesion on prostate magnetic resonance imaging avoids unnecessary biopsies
por: Jager, Auke, et al.
Publicado: (2022)

Prostate Cancer Tumour Features on Template Prostate-mapping Biopsies: Implications for Focal Therapy [Image: see text] ()
por: Singh, Paras B., et al.
Publicado: (2014)

Health Economic Evidence for Liquid- and Tissue-based Molecular Tests that Inform Decisions on Prostate Biopsies and Treatment of Localised Prostate Cancer: A Systematic Review
por: Degeling, Koen, et al.
Publicado: (2021)

Detailed Evaluation of Androgen Deprivation Overtreatment in Prostate Cancer Patients Compared to the European Association of Urology Guidelines Using Long-term Data from the European Randomised Study of Screening for Prostate Cancer Rotterdam
por: Hogenhout, Renée, et al.
Publicado: (2022)

Current techniques of prostate biopsy: an update from past to present
por: Noureldin, Mohamed Essam, et al.
Publicado: (2020)

The effect of delaying transperineal fusion biopsy of the prostate for patients with suspicious MRI findings—Implications for the COVID-19 era
por: Savin, Ziv, et al.
Publicado: (2021)

Optimal biopsy approach for detection of clinically significant prostate cancer
por: Ippoliti, Simona, et al.
Publicado: (2022)

Value of systematic sampling in an mp-MRI targeted prostate biopsy strategy
por: Connor, Martin J., et al.
Publicado: (2020)

Prognostic Histopathological and Molecular Markers on Prostate Cancer Needle-Biopsies: A Review
por: Hoogland, A. Marije, et al.
Publicado: (2014)

Predictors of clinically significant prostate cancer in biopsy-naïve and prior negative biopsy men with a negative prostate MRI: improving MRI-based screening with a novel risk calculator
por: van Riel, Luigi A.M.J.G., et al.
Publicado: (2022)

Biopsy interpretation of the prostate
por: Epstein, Jonathan I.

Prostate biopsy interpretation
por: Epstein, Jonathan I.

Learning curve for magnetic resonance imaging/ultrasound fusion prostate biopsy in detecting prostate cancer using cumulative sum analysis
por: Xu, Linhan, et al.
Publicado: (2023)

Schema and cancer detection rates for transperineal prostate biopsy templates: a review
por: Sidana, Abhinav, et al.
Publicado: (2022)

The Severity of Pain in Prostate Biopsy Depends on the Biopsy Sector
por: Rempega, Grzegorz, et al.
Publicado: (2023)

The use of prostate MR for targeting prostate biopsies
por: Kelley, R. Phelps, et al.
Publicado: (2019)

Diagnostic Performance of a Magnetic Resonance Imaging-directed Targeted plus Regional Biopsy Approach in Prostate Cancer Diagnosis: A Systematic Review and Meta-analysis
por: Hagens, Marinus J., et al.
Publicado: (2022)

Indications for a second prostate biopsy in patients suspected with prostate cancer after an initial negative prostate biopsy
por: Lee, Kwang Suk, et al.
Publicado: (2017)

Acute prostatitis after prostate biopsy under ciprofloxacin prophylaxis with or without ornidazole and pre-biopsy enema: analysis of 3.479 prostate biopsy cases
por: Balaban, Muhsin, et al.
Publicado: (2020)

Population‐based study of long‐term functional outcomes after prostate cancer treatment
por: Carlsson, Sigrid, et al.
Publicado: (2015)

Reducing prostate biopsies and magnetic resonance imaging with prostate cancer risk stratification
por: Davik, Petter, et al.
Publicado: (2022)

Comparison of Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging in Patients with Prostate Biopsy Indications
por: Altay, Mehmet Sefa, et al.
Publicado: (2022)

Prostate Biopsy in the Case of PIRADS 5—Is Systematic Biopsy Mandatory?
por: Malewski, Wojciech, et al.
Publicado: (2023)

Effect of information on prostate biopsy history on biopsy outcomes in the era of MRI-targeted biopsies
por: Lantz, Anna, et al.
Publicado: (2020)

The Patient Journey from Randomization to Detection of Prostate Cancer and Death: Results from ERSPC Rotterdam
por: Remmers, Sebastiaan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r67m1bp6mi14dna684cn3rd1nb